Table 2.
Univariate and Multivariate Analysis of Factors Associated with Overall Survival and Disease-Free Survival in Training Cohort
Clinicopathologic Variable | Total | OS | DFS | ||||
---|---|---|---|---|---|---|---|
Univariate | Multivariate Analysis | Univariate | Multivariate Analysis | ||||
P | RR (95 % CI) | P | P | RR (95 % CI) | P | ||
Age(years) | |||||||
≦42 | 61 | ||||||
> 42 | 47 | 0.424 | n.a. | n.a. | 0.454 | n.a. | n.a. |
FIGO stage | |||||||
Ia2 | 9 | 1 | 1 | ||||
Ib1 | 53 | ||||||
Ib2 | 21 | ||||||
IIa1 | 12 | ||||||
IIa2 | 13 | <0.001 | 1.697(1.128–2.555) | 0.011 | <0.001 | 1.681(1.148–2.463) | 0.008 |
Tumor size(cm) | |||||||
≦4 | 74 | 1 | |||||
> 4 | 34 | 0.035 | 0.650(0.203–2.078) | 0.467 | 0.068 | n.a. | n.a. |
Pathologic types | |||||||
Squamous cell carcinoma | 68 | ||||||
Adenocarcinoma | 40 | 0.688 | n.a. | n.a. | 0.921 | n.a. | n.a. |
Differentiation grade | |||||||
Well | 9 | ||||||
Moderate | 48 | ||||||
Poor | 51 | 0.209 | n.a. | n.a. | 0.117 | n.a. | n.a. |
Stromal invasion | |||||||
< 1/2 | 61 | 1 | 1 | ||||
≧1/2 | 47 | 0.011 | 1.740(0.535–5.662) | 0.357 | 0.012 | 1.327(0.507–3.474) | 0.565 |
Lymphovascular space invasion | |||||||
Yes | 14 | 1 | |||||
No | 94 | 0.115 | n.a. | n.a. | 0.046 | 0.629(0.190–2.080) | 0.447 |
Pelvic-lymph node metastasis | |||||||
Yes | 18 | 1 | 1 | ||||
No | 90 | 0.029 | 1.609 (0.646–4.011) | 0.307 | 0.014 | 2.211(0.788–6.206) | 0.132 |
Vaginal involvement | |||||||
Yes | 4 | ||||||
No | 104 | 0.824 | n.a. | n.a. | 0.862 | n.a. | n.a. |
Parametrial infiltration | |||||||
Yes | 3 | ||||||
No | 105 | 0.434 | n.a. | n.a. | 0.505 | n.a. | n.a. |
TRIM62 | |||||||
low | 67 | 1 | 1 | ||||
high | 41 | 0.008 | 0.200(0.046–0.873) | 0.032 | 0.005 | 0.168(0.039–0.728) | 0.017 |
Abbreviations: n.a. Not application, FIGO the International Federation of Gynecology and Obstetrics; The bold number inside the table reflected P < 0.05